ArticlePloS one2017

PI3Kδ inhibitor idelalisib in combination with BTK inhibitor ONO/GS-4059 in diffuse large B cell lymphoma with acquired resistance to PI3Kδ and BTK inhibitors.

Anella Yahiaoui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.